Summary
The Sten Linnarsson Lab at the Karolinska Institutet is inviting applications for a PhD student position focused on glioblastoma (GBM) immunology. This opportunity allows candidates to engage in groundbreaking research aimed at understanding immune dysfunction in GBM and developing novel immunotherapeutic strategies.
PhD Position in Glioblastoma Immunology, Karolinska Institutet, Solna, Stockholms län, Sweden
Designation
PhD Student in Glioblastoma Immunology
Research Area
- Cancer Immunology
- Brain Biology
- Single-Cell Analysis
- Tumor Microenvironment
Location
Karolinska Institutet, Solna, Stockholms län, Sweden
Eligibility/Qualifications
| Requirement | Details |
|---|---|
| General Eligibility | – Master’s degree or equivalent qualification (e.g., 240 credits with at least 60 at the Master level). |
| Specific Eligibility | – Proficiency in English (equivalent to English B/English 6 at Swedish upper secondary school). |
| Technical Skills | – Hands-on experience in laboratory work, single-cell transcriptomics, animal handling, and in vivo studies. |
| Desired Background | – Strong background in tumor immunology and brain tumor biology. |
| Additional Skills | – Programming skills (R/Python) are advantageous. |
Job Description
The PhD project will focus on:
- Characterizing infiltrated T-cell phenotypes in GBM.
- Analyzing the functional states influenced by specific microenvironments.
- Evaluating tumor reprogramming strategies to enhance immune responses.
- Utilizing single-cell transcriptomics and TCR sequencing.
- Establishing humanized orthotopic GBM mouse models to study tumor-immune interactions.
How to Apply
Applicants must submit their applications through the Varbi recruitment system, including the following documents:
- A personal letter and curriculum vitae.
- Degree projects and previous publications.
- Documentation certifying general and specific eligibility.
Last Date to Apply
Application Deadline: June 2, 2026
This scholarship offers candidates the chance to work in a multidisciplinary environment and conduct impactful research that aims to improve therapeutic strategies for glioblastoma.
